Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR, but resistances to gefitinib can arise through other mutations. It is marketed by AstraZeneca and Teva.
It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. |
Read full article at Wikipedia
|
InChI=1S/C2H8N2/c3-1-2-4/h1-4H2 |
PIICEJLVQHRZGT-UHFFFAOYSA-N |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
GABA agonist
A drug that binds to and activates gamma-aminobutyric acid receptors.
|
|
GABA agonist
A drug that binds to and activates gamma-aminobutyric acid receptors.
|
|
View more via ChEBI Ontology
1,2-ethanediamine
|
IUPAC
|
en
|
IUPAC
|
ethylenediamine
|
IUPAC
|
107-15-3
|
CAS Registry Number
|
ChemIDplus
|
107-15-3
|
CAS Registry Number
|
NIST Chemistry WebBook
|
1098
|
Gmelin Registry Number
|
Gmelin
|
605263
|
Reaxys Registry Number
|
Reaxys
|
|